race oncology (asx:rac) leukemia drug candidate update
Published 5 years ago • 414 plays • Length 5:20Download video MP4
Download video MP3
Similar videos
-
33:20
race oncology (asx:rac) | webinar with daniel tillett | 05/06/24
-
54:22
race oncology (asx:rac) investor briefing - melbourne 20th oct 2022
-
12:59
race oncology (asx:rac) ceo, phillip lynch presents at v-con
-
32:00
race oncology (asx: rac) day 2 of the ird invest 2021 conference.
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
38:32
investor presentation
-
26:19
rnl 2021 - eular 2019 and acr 2020 ra treatment guidelines - dr. alan matsumoto
-
16:58
arovella therapeutics (asx:ala) - webinar presentation
-
6:49
race oncology receives positive results from aml trial of bisantrene
-
0:52
asx market open video 11th june 🚀
-
6:42
race oncology looks to accelerate clinical development of bisantrene
-
1:01
asx market open video 11th june
-
32:00
race oncology (asx: rac) day 2 of the ird invest 2021 conference.
-
19:11
sharecafe 'hidden gems' webinar - race oncology asx:rac
-
1:31:25
race oncology asx rac 2023 annual general meeting
-
1:44
what is race oncology?
-
1:56
race oncology featured on nbn news
-
1:31:49
race oncology investor briefing
-
8:00
race oncology highlights impressive bisantrene clinical data
-
5:10
race oncology receives fda orphan drug designation extension for bisantrene rc220
-
4:16
race oncology's breakthrough in cancer cell treatment